Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
13.34
+0.03 (0.23%)
At close: May 13, 2026, 4:00 PM EDT
13.34
0.00 (0.00%)
After-hours: May 13, 2026, 5:37 PM EDT

Organon & Co. Revenue

Organon & Co. had revenue of $1.46B in the quarter ending March 31, 2026, a decrease of -3.50%. This brings the company's revenue in the last twelve months to $6.16B, down -2.08% year-over-year. In the year 2025, Organon & Co. had annual revenue of $6.22B, down -2.92%.

Revenue (ttm)
$6.16B
Revenue Growth
-2.08%
P/S Ratio
0.57
Revenue / Employee
$616,300
Employees
10,000
Market Cap
3.50B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.22B-187.00M-2.92%
Dec 31, 20246.40B140.00M2.24%
Dec 31, 20236.26B89.00M1.44%
Dec 31, 20226.17B-130.00M-2.06%
Dec 31, 20216.30B-228.00M-3.49%
Dec 31, 20206.53B-1.25B-16.01%
Dec 31, 20197.78B-2.00B-20.46%
Dec 31, 20189.78B-723.00M-6.89%
Dec 31, 201710.50B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Pfizer63.32B
Sanofi54.60B
Novo Nordisk50.57B
Bristol-Myers Squibb Company48.48B
GSK plc43.29B
Amgen37.22B
Gilead Sciences29.74B
Biogen9.94B
Revenue Rankings